Listen to the new podcast episode of Medical Affairs Unscripted, featuring Nick Sen and Peg Crowley-Nowick focused on Driving Commercial Success in Medical Affairs

If you're building a biotech and medical affairs isn't at the table yet, this episode is for you. Listen anywhere you get your podcasts or here: buff.ly/SqyQQqZ

#MedicalAffairs #DrugDevelopment #ClinicalDevelopment #MarketAccess #Launch #MedicalAffairsUnscripted

We're looking forward to the 2026 CancerCare Spring Gala next week, and proud to be an event sponsor.

If you'll be there, we'd love to say hi! For more information on the event, visit donate.cancercare.org/donate/gala2...

#CancerCare #CancerResearch #Oncology

#ArtificialIntelligence #AI governance and oversight is vital for evidence synthesis, #regulatory strategy, pricing decisions, #HTA, portfolio prioritization, and #marketaccess modeling. Learn more by checking out our article in Silicon Valleys Journal: buff.ly/5u0RWG8#AIGo...

Cherry blossoms in Washington, D.C. promoting Lumanity's participation in the ISMPP annual meeting

Join us at the upcoming #ISMPPAnnual where we'll be exhibiting and presenting! Visit us at booth 11, meet our experts, and check out our new Evidence Navigator Hub and Expert Navigator platform. Explore more: buff.ly/7RMj3VJ

#MedicalPublications #MedPubs #MedComms

How Pharma Can Leverage Ai-Driven Synthetic Personas - Webinar wrap up with Lumanity

In our recent webinar, "Using AI-driven synthetic personas to take your insights further," we cover how pharma teams are beginning to leverage synthetic personas. Check out the webinar highlights: buff.ly/xPyqWos

#SyntheticPersonas #HealthcareInsights #AiInsights

Lumanity moderated webinar hosted by MAPS "Optimizing Content for MSL-led Learning Journeys: An Omnichannel Perspective"

Join us as we explore how to strategically design and implement #MSL-led content pathways anchored in a scientific narrative, seamlessly integrating them into a broader #omnichannel strategy. Register: buff.ly/5Q0JYUU

#MedicalScienceLiaisons #HCP #MedicalAffairs

We're just a couple weeks away from the 2026 #ClinicalOutcomeAssessment Program Annual Meeting in Washington, D.C. If you'll be at the meeting, let's connect! Email contact@lumanity.com to find time to meet. buff.ly/vmcRX6O

#COA #OutcomesResearch #PatientReportedOutcomes

Text: View. The NICE Conference 2026. Collaborations in a Fast-Evolving Landscape. Lumanity logo.

At the NICE Conference 2026 it was clear that the pace of change in UK HTA is accelerating, and organizations need to be ready.

Our new article reflects on the key themes from the conference and the implications for companies preparing for NICE engagement.

lumanity.com/perspectives...

Text: ISPOR: May 17 - 20, 2026 | Philadelphia, USA. Lumanity is going to ISPOR 2026! Meet the team at booth #624. Lumanity logo.

Heading to ISPOR 2026 in Philadelphia this May? We are too!

The Lumanity team will be on-site at booth #624, ready to help you navigate evolving policy shifts, shape compelling value stories, and share insights.
Find out more on our website: lumanity.com/events/ispor...

#ISPOR2026 #HEOR #RWE #HTA

Patient Engagement codes of conduct and rules of engagement webinar on March 31. Image features people sitting around a table having a discussion

Join us for a virtual Patient Engagement Open Forum (PEOF) event as we explore the key rules of engagement for pharma-patient interactions.

Register and access other patient engagement content: buff.ly/cIcTEWZ

#PatientEngagement #PFMD #Compliance

Our latest podcast addresses how Medical Affairs can move beyond data delivery to translate medical insights into strategy, strengthen cross-functional collaboration, and better support physicians and patients. Listen: buff.ly/dzRcoQc

#CMO #MedicalAffairs #MedAffairs

NICE Conference: March 17, 2026 | Manchester, UK. Are You Going to the NICE Conference 2026 Next Week? Lumanity logo.

Don't miss the chance to connect with Lumanity’s Emily Breislin and Hannah Kilvert at the NICE Conference 2026 next week. lumanity.com/events/nice-...

The MFN Terminology Maze. What pharmaceutical leaders need to know about Most Favored Nation pricing in 2026. Lumanity logo.

Cutting through the MFN confusion. Voluntary agreements, TrumpRx, CMMI models all called “MFN,” all fundamentally different.

Our new article clarifies each MFN pathway and the implications for your strategy.

Read it here: lumanity.com/perspectives...

#MarketAccess #DrugPricing #MFN

Text: Podcast. Mental Health in Caregivers. Real Stories, Real Voices on Mental Health. Lumanity logo.

Caring for a family member living with disease can be deeply meaningful—but it can also affect your mental health. And too often, the responsibility for day-to-day care falls to women. Here, participants discuss what better support could look like: lumanity.com/perspectives... #IWD #MentalHealth

RWE Guidance on PASS studies and staying ahead.

The #RWE regulatory landscape has shifted and for long running post-authorization safety studies (#PASS), this evolution introduces challenges.

Staying ahead with these PASS guidance developments is critical: buff.ly/OPSIGsv

Woman and pediatric patient - RWE expertise in Dravet Syndrome

Identifying patients with #DravetSyndrome in #RWD is difficult due to the small patient population, but worth it – #RWE is vital for improving patient care, lowering healthcare costs, and addressing unmet need for patients.

Read our factsheet to explore more: buff.ly/hMYVFsR

#RareDisease

Today is #RareDiseaseDay, which raises awareness around rare diseases and continues the campaign for improved access to treatment and medical representation. We have shared two new rare disease patient advocacy stories to mark the day. Check them out: lumanity.com/perspectives/

Text: Voices of Rare Disease: Perspectives Across the Community. Lumanity logo.

This #RareDiseaseDay, watch the first vignette in our Voices of Rare Disease series to hear how advocate İpek Badırgalı’s journey moves from a life-changing family experience to global action after her niece was diagnosed with spinal muscular atrophy (SMA). lumanity.com/perspectives...

Jason Madison wearing a tshirt that reads "In My Rare Era". Text: Rare Disease Day 2026. "I think about some of the people I've met and things I've done, and I think 'would I really be willing to give that up?'" Jason Madison, Hunter Syndrome patient advocate and Lumanity Patient Council member. Lumanity logo.

In this Q&A to mark #RareDiseaseDay, we sat down with Jason Madison to talk about being diagnosed with Hunter syndrome as a young child, and what he’s learnt from a life with the condition – namely, to expect things to turn out different than you expected. Read now: lumanity.com/perspectives...

Text: World EPA: March 3-4, 2026 | Amsterdam, The Netherlands. Are You Going to the 2026 World EPA Congress Next Week? Lumanity logo.

Don't miss the chance to connect with Lumanity’s Suzette Matthijsse and Enzo Straccia at the World EPA Congress next week.

Get in touch to book some time with Suzette and Enzo and find out how Lumanity can illuminate the path to market for your products.

lumanity.com/events/world...

Gain actionable insights for biotech founders, clinical development leaders, medical affairs professionals, and emerging CMOs navigating the path from early development to launch.

Listen to the latest episode of our podcast: buff.ly/4IYeX3W

#MedicalAffairs #ClinicalDevelopment #EarlyStage #Biotech

Text: View. Preparing for JCA 2028. Can orphan drug manufacturers overcome the challenges?

From 2028, treatments for rare diseases will fall within the scope of EU Joint Clinical Assessment (JCA)

With #RareDiseaseDay this weekend, we are sharing our insights on what manufactures can expect and how important it is to start preparing now. lumanity.com/perspectives...

Register for the upcoming webinar on using AI-driven synthetic personas to take healthcare insights further

Join us as we address opportunities and real-world challenges in deploying synthetic personas, building trust in outputs, managing expectations, and applying the method to imperfect segmentation data.

Register: pharmaphorum.com/sales-market...

#SyntheticPersonas #DataSegmentation

Meet with Lumanity during the EPHMRA UK Chapter Meeting 2026 in London

Masha Eletskaya will be in attendance at the upcoming EPHMRA UK Chapter Meeting. If you're planning to attend, be sure to connect with Masha in London!

For more information about the event, visit www.ephmra.org/events/81

#EPHMRA #MarketResearch #HealthcareInsights

Text: View. The Role of Clinical Outcomes Assessments in Integrated Evidence Generation. Lumanity logo.

Patient-centered data should do more than meet regulatory requirements. We explore how COAs can inform market access, commercial strategy, and trial design—and how Evidence Navigator™ aligns COA insights with an evidence generation plan that serves all stakeholders. buff.ly/0eSwVvX

Download our infographic on how PASS is evolving and why staying aligned with these developments is critical

The regulatory landscape for #RealWorldEvidence has accelerated over the past decade. Proactive planning and staying aligned with these developments is crucial. Stay ahead of delays, increased costs, and misalignment risks: buff.ly/OPSIGsv

#RWE #PASS #RegulatoryGuidance

Text: Whitepaper Integrated Evidence Generation Planning. From strategy to execution. Lumanity logo.

Evidence Navigator™ Compass our strategy-led engagement model, provides leadership across the IEGP process. We combine expertise with structured cross-functional alignment to define strategy, identify evidence gaps, and build actionable, future-ready roadmaps.

Read our whitepaper: buff.ly/wsXEvlq

Text: The 2026 Perfect Storm. Navigating the Payer Headwinds. Lumanity logo.

The healthcare decision making environment in 2026 is more complex than ever. In our recent article, we, explore how IRA reforms, a high impact pipeline, and increasing scrutiny of PBM and pricing models are shaping payer priorities for the year ahead.

Find out more: lumanity.com/perspectives...

Download our reference guide for insights into AI search optimization

Ready for an Engine Optimization Health Check? Don’t let your brand fade from the conversation — take control of your digital narrative. Download our full perspective and checklist: buff.ly/HiJB2fm

#BrandVisibility #SEO #AEO #GEO

Lantern imagery and text reading "Ramadan Mubarak!"

Ramadan is expected to start this evening at sundown, beginning a sacred month in the Islamic calendar dedicated to fasting, prayer, reflection, and community. We wish a peaceful and blessed Ramadan to everyone starting this holy month.